Bruker (BRKR)
(Delayed Data from NSDQ)
$80.97 USD
+0.38 (0.47%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $80.94 -0.03 (-0.04%) 7:58 PM ET
2-Buy of 5 2
C Value C Growth B Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
BRKR 80.97 +0.38(0.47%)
Will BRKR be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for BRKR based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BRKR
Earnings Preview: Bruker (BRKR) Q1 Earnings Expected to Decline
Bruker (BRKR) Introduces Magnet Technology for NMR Adoption
BRKR: What are Zacks experts saying now?
Zacks Private Portfolio Services
Bruker Corporation (BRKR) Hits 52-Week High: What's Driving It?
Why Is Bruker (BRKR) Up 15.7% Since Last Earnings Report?
Bruker (BRKR) Up 20.7% Since Last Earnings: What's Driving It?
Other News for BRKR
Bruker Further Enhances Clinical Microbiology & Infection Diagnostics Portfolio at ESCMID Global 2024 Conference
Bruker Announces Date and Time of First Quarter 2024 Earnings Release and Webcast
Bruker Corporation: An Aggressive Acquisition Strategy
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Owens & Minor (OMI), Bruker (BRKR) and Gilead Sciences (GILD)
Bruker to Acquire the NanoString Business in an Asset Deal